Global Cardiovascular Ultrasound System Market – Industry Trends and Forecast to 2031

Global Cardiovascular Ultrasound System Market, By Test Type (Transthoracic Echocardiogram, Transoesophageal Echocardiogram, Stress Echocardiogram, and Other Echocardiograms), Technology (2D Ultrasound, 3D and 4D Ultrasound, and Doppler Imaging), Device Display (Colour Display and Black and White (B/W) Display), End-User (Hospital and Cardiology Centres, Home and Ambulatory Care Settings, Research Institutes, Medical Device, and Pharmaceutical Companies, and Other End Users) – Industry Trends and Forecast to 2031.

Cardiovascular Ultrasound System Market Analysis and Size

According to the 2022 American Heart Association (AHA) report, approximately 244.1 million individuals globally were diagnosed with ischemic heart disease (IHD) as of 2020, with North Africa, the Middle East, Central and South Asia, and Eastern Europe experiencing the highest prevalence rates. This trend is anticipated to continue due to widespread risk factors such as hypertension, obesity, smoking, diabetes, and sedentary lifestyles. As a result, the demand for ultrasound in diagnosing, monitoring, and treating cardiovascular diseases is expected to rise, driving growth in the cardiovascular ultrasound system market throughout the forecast period. The cardiovascular ultrasound system market plays a pivotal role in modern cardiology, offering essential diagnostic capabilities and monitoring tools for cardiovascular diseases worldwide.

Global cardiovascular ultrasound system market size was valued at USD 1.84 billion in 2023 and is projected to reach USD 2.80 billion by 2031, with a CAGR of 5.37% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation       

Market Definition

A cardiovascular ultrasound system is a medical device used for non-invasive imaging of the heart and surrounding blood vessels. It utilizes high-frequency sound waves (ultrasound) to create real-time images of the heart's anatomy, chambers, valves, and blood flow dynamics. This imaging technology helps healthcare professionals diagnose and monitor various cardiovascular conditions such as heart disease, heart valve disorders, congenital heart defects, and abnormalities in blood circulation.      

Cardiovascular Ultrasound System Market Dynamics

Drivers

• Growing Prevalence of Cardiovascular Diseases  

The increasing prevalence of cardiovascular diseases, encompassing conditions such as heart disease and hypertension, is a significant driver for the cardiovascular ultrasound system market. As these diseases continue to rise globally due to aging populations, sedentary lifestyles, and dietary habits, there is a heightened demand for early diagnosis and continuous monitoring. According to the June 2021 update from the World Health Organization (WHO), cardiovascular diseases (CVDs) remain the primary cause of global mortality, with approximately three-quarters of CVD-related deaths occurring in low- and middle-income countries. Cardiovascular ultrasound systems play a crucial role in this landscape by enabling healthcare providers to detect abnormalities in cardiac function, assess vascular health, and guide treatment decisions. This high mortality underscores an increasing demand for disease diagnostics and monitoring, which is poised to drive growth in the cardiovascular ultrasound system market.

• Technological Advancements in Ultrasound Imaging      

Innovations such as AI-driven algorithms for automated measurements and enhanced imaging quality are revolutionizing diagnostic capabilities. AI facilitates real-time image analysis, enabling faster and more accurate detection of cardiovascular conditions. These advancements not only streamline workflow and enhance diagnostic accuracy but also improve efficiency in clinical settings. For instance, in October 2020, GE Healthcare obtained 510k clearance from the United States Food and Drug Administration for its ultra-edition package of vivid cardiovascular ultrasound systems. This package incorporates new artificial intelligence (AI)-based features designed to enable clinicians to conduct faster and more consistent exams with improved repeatability. By integrating AI with ultrasound systems, healthcare providers can achieve higher diagnostic confidence, optimize treatment planning, and deliver personalized care tailored to individual patient needs, thus driving market growth and adoption.            

• Rising Adoption of Non-Invasive Diagnostic Techniques   

Non-invasive procedures reduce patient discomfort, minimize recovery times, and lower the risk of complications compared to traditional invasive methods. Cardiovascular ultrasound systems play a pivotal role in this shift by offering detailed insights into cardiac structure and function without the need for surgical intervention. This capability not only enhances patient satisfaction but also supports early detection of cardiovascular abnormalities, facilitates timely interventions, and improves overall healthcare outcomes. As healthcare systems prioritize patient safety and comfort, the demand for non-invasive cardiovascular ultrasound systems is expected to continue growing, driving market expansion.

Opportunities

• Development of Next-Generation Cardiovascular Ultrasound Systems   

Continued advancements in AI and machine learning technologies are opening new avenues for the development of next-generation cardiovascular ultrasound systems. AI-powered algorithms enable real-time image analysis, automated measurements, and decision support systems that enhance diagnostic accuracy and clinical workflow efficiency. These technologies hold promise for improving the detection of subtle cardiac abnormalities, predicting disease progression, and optimizing treatment strategies tailored to individual patient profiles. By harnessing the power of AI, manufacturers can innovate advanced ultrasound systems capable of delivering precise diagnostic insights, supporting personalized medicine approaches, and creating new opportunities for the market in cardiovascular care.           

• Personalized Medicine and Point-of-Care Testing     

The growing demand for personalized medicine and point-of-care testing solutions is driving the evolution of handheld and smartphone-integrated ultrasound devices within the cardiovascular ultrasound system market. These compact and portable devices offer flexibility in clinical settings, enabling healthcare providers to perform cardiac evaluations conveniently at the patient's bedside or in remote locations. They cater to the increasing need for rapid diagnostic assessments, early intervention, and personalized treatment plans tailored to individual patient needs. By integrating ultrasound technology with mobile platforms and cloud-based solutions, manufacturers are facilitating seamless data integration, real-time collaboration among healthcare teams, improved patient outcomes, and expanding market opportunities globally.

Restraints/Challenges

• High Cost of Ultrasound Equipment

The high initial cost and ongoing maintenance expenses associated with cardiovascular ultrasound systems pose significant barriers to market penetration, particularly in resource-constrained healthcare settings. The capital investment required for acquiring advanced ultrasound equipment, coupled with expenses for training healthcare staff and maintaining equipment functionality, can strain limited budgets. This financial burden often deters healthcare facilities from investing in new technologies or upgrading existing systems, thereby limiting access to advanced diagnostic capabilities and innovative treatment options for patients.        

• Challenges in Reimbursement Policies

Inconsistent reimbursement policies and varying reimbursement rates for cardiovascular ultrasound procedures across different regions and healthcare systems present challenges for market growth and adoption. Reimbursement complexities can affect healthcare providers' ability to recover costs associated with ultrasound services, impacting their willingness to invest in advanced equipment and integrate new technologies into clinical practice. Lack of uniformity in reimbursement guidelines and delays in reimbursement approvals further hinder market expansion efforts and innovation in cardiovascular ultrasound systems.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In May 2024, Siemens Healthineers introduced advanced AI applications for its Acuson Sequoia ultrasound system, alongside a new 4D transesophageal (TEE) transducer designed for cardiology examinations. Among the new AI-driven cardiology features are AI Measure, which automates the acquisition of essential measurements for routine echocardiography exams, and 2D HeartAI, enhancing efficiency and workflow for cardiac strain imaging procedures         
• In February 2024, Royal Philips announced the integration of artificial intelligence into its cardiac ultrasound devices and broader cardiac care offerings aimed at enhancing clinical confidence and operational efficiency. The Philips Ultrasound Compact System 5500 CV, a portable solution, now incorporates an AI-driven automation tool known as automated strain quantification. This tool aids in evaluating the left ventricle's function, a critical metric for assessing heart health
• In August 2023, Siemens Healthineers unveiled the Acuson Origin, a specialized cardiovascular ultrasound system featuring advanced artificial intelligence capabilities, during the annual meeting of the European Society of Cardiology (ESC)

Cardiovascular Ultrasound System Market Scope

The market is segmented on the basis of test type, technology, device display, and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Test Type

• Transthoracic Echocardiogram
• Transoesophageal Echocardiogram
• Stress Echocardiogram
• Other Echocardiograms

Technology

• 2D Ultrasound
• 3D and 4D Ultrasound
• Doppler Imaging

Device Display

• Colour Display
• Black and White (B/W) Display

End-User

• Hospital and Cardiology Centres
• Home and Ambulatory Care Settings
• Research Institutes
• Medical Device, and Pharmaceutical Companies
• Other End Users

Cardiovascular Ultrasound System Market Regional Analysis/Insights

The market is analyzed and market size insights and trends are provided by country, test type, technology, device display, and end-user as referenced above.

The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.

North America is expected to dominate the market due to expanding preventive healthcare practices and the widespread adoption of advanced technologies. The region's robust healthcare infrastructure further accelerates market growth.                

Asia-Pacific is expected to witness significant growth during the forecast period due to the increasing prevalence of chronic diseases. Favorable reimbursement policies and regulatory frameworks are also expected to bolster market expansion in this area during the forecast period. 

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.

Competitive Landscape and Cardiovascular Ultrasound System Market Share Analysis

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Some of the major players operating in the market are:

• GE Healthcare (U.S.)
• Koninklijke Philips N.V. (Netherlands)
• FUJIFILM Holdings Corporation (Japan)
• Siemens Healthineers AG (Germany)
• Hitachi Medical Corporation (Japan)
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
• Samsung Electronics Co. Ltd. (South Korea)
• Canon Medical Systems (Japan)
• Chison Medical Imaging Co. Ltd. (China)
• Esaote SPA (Italy)
• Kalamed GmbH Medical Systems (U.S.)
• Unetixs Vascular, Inc. (U.S.)